Sanjay Shukla
Vermögen: 1 163 $ am 30.09.2026
Vermögen: 1 163 $ am 30.09.2026
Dr. Sanjay S.
Shukla, MD, is a President, Chief Executive Officer & Director at aTyr Pharma, Inc. He is on the Board of Directors at aTyr Pharma, Inc. Dr. Shukla was previously employed as a Vice President & Head-Integrated Medical Services by Novartis AG and a Chief Executive Officer by Rxmd, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from the University of Maryland and a doctorate degree from Howard University College of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.08.2026 | 3’839 ( 0% ) | 1 163 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ATYR PHARMA, INC. | Vorstandsvorsitzender | 01.11.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.04.2015 |
Rxmd, Inc. | Vorstandsvorsitzender | 01.09.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rxmd, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen